Assay Detail
Binding
CHEMBL5608463
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of human recombinant catalytic domain TTBK1 (1 to 415 residues) extracted from Escherichia coli BL21 (DE3) incubated for 1 hr by spectrophotometric analysis
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 1 | 8.57 | 8.57 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5193906 | — | — | 1 | 8.57 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5193906 | — | IC50 | = | 2.7 | nM | 8.57 |